Psychiatry and Neurology, Neurology · Detroit, MI
NPI
1528270808
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
4201 Saint Antoine St, Ste 8a & 8b
Detroit, MI, 48201
Phone (313) 745-4275
Groups this clinician bills Medicare through
Medicare paid, 2024
$3,994
63 services
Medicare patients, 2024
53
Average age 63
Drug cost, 2024
$2.9M
964 prescriptions
Company payments, 2025
$18K
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Evanthia Bernitsas was code 99214 (office e&m - established), 44 times for 38 patients. In total Evanthia Bernitsas billed 63 services in 8 codes, and Medicare paid $3,994.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-10-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 44 | 38 | $63.61 | $2,799 |
By year: 2022 $11K for 154 services; 2023 $11K for 149 services; 2024 $3,994 for 63 services.
Medicare prescription drug claims, 2024
In 2024, the drug Evanthia Bernitsas prescribed most often to Medicare patients was Gabapentin, with 119 prescriptions and refills. In total Evanthia Bernitsas wrote 964 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 119 | 185 | 32 | $1,676 |
| Copaxone Glatiramer Acetate | 88 | 97 | 12 | $586K |
| Baclofen Generic | 73 | 173 | 24 | $2,266 |
| Glatiramer Acetate Generic | 56 | 56 | Under 11 | $110K |
| Pregabalin Generic | 37 | 49 | Under 11 | $479 |
| Tecfidera Dimethyl Fumarate | 35 | 55 | Under 11 | $480K |
| Dimethyl Fumarate Generic | 32 | 50 | Under 11 | $97K |
| Glatopa Glatiramer Acetate | 28 | 28 | Under 11 | $68K |
| Carbamazepine Generic | 27 | 32 | Under 11 | $978 |
| Tizanidine Hcl Generic | 26 | 38 | Under 11 | $1,228 |
| Kesimpta Pen Ofatumumab | 24 | 24 | Under 11 | $203K |
| Amantadine Amantadine Hcl | 20 | 46 | Under 11 | $1,062 |
| Rebif Rebidose Interferon Beta-1a/Albumin | 20 | 20 | Under 11 | $207K |
| Oxybutynin Chloride Generic | 20 | 38 | Under 11 | $428 |
| Levetiracetam Generic | 19 | 19 | Under 11 | $275 |
Brand drugs: 265 claims; generic drugs: 699 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Evanthia Bernitsas $18K ($14K in general payments such as food, travel and fees and $4,293 for research) from 9 companies. The largest payer was Vanda Pharmaceuticals Inc. with $7,883.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.